These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tobacco amblyopia. Can Med Assoc J; 1970 Feb; 102(4):420. PubMed ID: 5414928 [No Abstract] [Full Text] [Related]
4. Hydroxocobalamin versus cyanocobalamin in the treatment of tobacco amblyopia. Chisholm IA; Bronte-Stewart J; Foulds WS Lancet; 1967 Aug; 2(7513):450-1. PubMed ID: 4166110 [No Abstract] [Full Text] [Related]
5. Letter: Cyanocobalamin. Johnson PA S Afr Med J; 1975 Aug; 49(33):1331. PubMed ID: 1154201 [No Abstract] [Full Text] [Related]
6. Response of metabolic encephalopathy to treatment with cyanocobalamin. Bronte-Stewart J; Chisholm IA; Lewis DR Scott Med J; 1968 Aug; 13(8):274-6. PubMed ID: 5676284 [No Abstract] [Full Text] [Related]
7. Whole blood cyanide levels in patients with tobacco amblyopia. Jestico JV; O'Brien MD; Teoh R; Toseland PA; Wong HC J Neurol Neurosurg Psychiatry; 1984 Jun; 47(6):573-8. PubMed ID: 6610725 [TBL] [Abstract][Full Text] [Related]
8. Biochemical observations in toxic optic neuropathy. Chisholm IA; Pettigrew AR Trans Ophthalmol Soc U K (1962); 1970; 90():827-38. PubMed ID: 5283437 [No Abstract] [Full Text] [Related]
9. Red cell glutathione in tobacco amblyopia. Pettigrew AR; Fell GS; Chisholm IA Exp Eye Res; 1972 Sep; 14(2):87-90. PubMed ID: 5070230 [No Abstract] [Full Text] [Related]
10. [Cyanide with vitamin B12 deficiency as the cause of experimental tobacco amblyopia]. Oku H; Fukushima K; Miyata M; Wakakura M; Ishikawa S Nippon Ganka Gakkai Zasshi; 1991 Feb; 95(2):158-64. PubMed ID: 2053526 [TBL] [Abstract][Full Text] [Related]
11. Cyanocobalamin--a case for withdrawal: discussion paper. Freeman AG J R Soc Med; 1992 Nov; 85(11):686-7. PubMed ID: 1474554 [No Abstract] [Full Text] [Related]
16. The optic neuropathy of pernicious anemia. Foulds WS; Chisholm IA; Stewart JB; Wilson TM Arch Ophthalmol; 1969 Oct; 82(4):427-32. PubMed ID: 5344936 [No Abstract] [Full Text] [Related]
17. The investigation and therapy of the toxic amblyopias. Foulds WS; Chisholm ; Bronte-Stewart J; Reid HC Trans Ophthalmol Soc U K (1962); 1970; 90():739-63. PubMed ID: 5314698 [No Abstract] [Full Text] [Related]
18. Interference of the cyanide antidote hydroxocobalamin with carboxyhemoglobin measurements should not limit clinical use in suspected or confirmed cyanide poisoning. Borron SW; Uhl W; Nolting A; Hostalek U Ann Emerg Med; 2007 Nov; 50(5):624-5; author reply 626. PubMed ID: 17963990 [No Abstract] [Full Text] [Related]
19. Visual field examination in the toxic and nutritional optic neuropathies. Friedmann AI Trans Ophthalmol Soc U K (1962); 1970; 90():795-808. PubMed ID: 5283436 [No Abstract] [Full Text] [Related]
20. Drug and nutritional factors in optic neuropathy. Crews SJ; James B; Marsters JB; West RH Trans Ophthalmol Soc U K (1962); 1970; 90():773-94. PubMed ID: 5283435 [No Abstract] [Full Text] [Related] [Next] [New Search]